P.3.10 The role of CYP2D6 gene in treatment resistant schizophrenia and the effectiveness of treatment resistant schizophreniaSosin, D.; Ivashchenko, D.; Sychev, D.; Ivanov, M. · European Neuropsychopharmacology · 2019

The Group of Treatment Resistant Schizophrenias. Heterogeneity in Treatment Resistant Schizophrenia (TRS)Kinon, Bruce J. · Frontiers in Psychiatry · 2019

Clozapine in treatment resistant schizophreniaVerhoeven, W.M.A. · 1992

MANAGEMENT OF TREATMENT RESISTANT SCHIZOPHRENIAPalia, S. S.; Huckle, P. · Clinical Neuropharmacology · 1992

Management of treatment resistant schizophreniaJones, S; Castle, DJ · African Journal of Psychiatry · 2006

Systemic review: High dose olanzapine treatment for treatment resistant schizophreniaAzvee, Z.; Lally, J. · European Psychiatry · 2017

Systemic review: High dose olanzapine treatment for treatment resistant schizophreniaAzvee, Z.; Lally, J. · European Psychiatry · 2017

High dose olanzapine in treatment resistant schizophreniaM.A. Launer · 1998

Editorial boardJohnstone, EveC.; Frith, C.D.; Crow, T.J.; Carney, M.W.P.; Price, J.S. · Deep Sea Research Part A. Oceanographic Research Papers · 1992

PHENELZINE AND ACETYLATOR STATUSCarr, A.; Johnstone, EveC. · The Lancet · 1974

HOW DOES E.C.T. WORK?Crow, T.J; Johnstone, EveC; Frith, C.D · 1978

ACETYLATOR STATUS AND RESPONSE TO PHENELZINETilstone, WilliamJ; Johnstone, EveC · 1978

MECHANISM OF ACTION OF NEUROLEPTIC DRUGSSchiff, A.A; Crow, T.J; Johnstone, EveC · 1978

NORTHWICK PARK ECT TRIALLenox, RobertH.; Weaver, LelonA.; Gangadhar, B.N.; Kalyanasundaram, S.; Kapur, R.L.; Maggs, Ronald; Johnstone, EveC.; Crow, T.J.; Frith, C.D.; Lawler, P.G. · 1981

CEREBRAL ATROPHY AND COGNITIVE IMPAIRMENT IN CHRONIC SCHIZOPHRENIACrow, T.J.; Johnstone, EveC. · 1977